23. TWO RECURRENT CASES OF DERMATOFIBROSARCOMA PROTUBERANS: LESSONS IN DIAGNOSIS AND SURGICAL MANAGEMENT

Pham Thanh Nha1, Le Van Tho1, Ngo Viet Nhuan2, Nguyen Tan Hung2, Nguyen Khanh Linh1
1 Hospital for Traumatology and Orthopaedics at Ho Chi Minh city
2 University of Medicine and Pharmacy at Ho Chi Minh city

Main Article Content

Abstract

Dermatofibrosarcoma protuberans (DFSP) is a rare, locally aggressive cutaneous sarcoma that often mimics benign lesions, leading to delayed diagnosis and high recurrence risk. We present two diagnostically challenging cases. The first involved a 15-year-old girl with a painless nodule on the index finger. She underwent two resections without prior biopsy. An incisional biopsy suggested dermatofibroma, and two subsequent resections were performed. Recurrences led to index ray amputation. Final histopathology confirmed dermatofibrosarcoma protuberans with diffuse CD34 positivity. The second case involved a 51-year-old woman with a painful, pruritic nodule on the left thigh that recurred after excision and persisted for nine years. MRI showed a subcutaneous mass, and biopsy confirmed dermatofibrosarcoma protuberans. Wide local excision with 2-3 cm margins to the fascia was performed. Preoperative skin mapping and margin orientation enabled precise pathological assessment and allowed for targeted re-excision if needed. Skin undermining was avoided, and closure achieved with a skin graft. Both cases have shown no recurrence during follow-up and achieved acceptable functional outcomes. These cases emphasize the need for early biopsy and CD34 immunostaining in atypical or persistent skin lesions. Wide excision with accurate surgical margin assessment is critical for curative treatment and recurrence prevention.

Article Details

References

[1] Board WCoT.E. Dermatofibrosarcoma protuberans. In: Board WCoTE, editor. WHO Classification of Tumours: Soft Tissue and Bone Tumours, 5th ed. Lyon: International Agency for Research on Cancer, 2020, p. 100-3.
[2] Saiag P, Lebbe C, Brochez L, Emile J.F, Forsea A.M, Harwood C et al. Diagnosis and treatment of dermatofibrosarcoma protuberans. European interdisciplinary guideline & #x2013, update 2024. European Journal of Cancer, 2025, 218.
[3] Sheidaei S, Salehi M, Abedian Kenari F, Jafari H.R. Dermatofibrosarcoma protuberans challenges: a case series and review of the literature. J Med Case Rep, 2023, 17 (1): 18.
[4] Bordeaux J, Blitzblau R, Aasi S.Z, Alam M, Amini A, Bibee K et al. Dermatofibrosarcoma Protuberans, Version 1, 2025, NCCN Clinical Practice Guidelines In Oncology. J Natl Compr Canc Netw, 2025, 23 (1).
[5] van Houdt W.J. Margins in DFSP Reconsidered: Primum Non Nocere. Ann Surg Oncol, 2020, 27 (3): 634-6.
[6] Farma J.M, Ammori J.B, Zager J.S, Marzban S.S, Bui M.M, Bichakjian C.K et al. Dermatofibrosarcoma protuberans: how wide should we resect? Ann Surg Oncol, 2010, 17 (8): 2112-8.
[7] Durack A, Gran S, Gardiner M, Jain A, Craythorne E, Proby C et al. A 10-year Review of Surgical Management of Dermatofibrosarcoma Protuberans. British Journal of Dermatology, 2020, 184.
[8] Hao X, Billings S.D, Wu F, Stultz T.W, Procop G.W, Mirkin G et al. Dermatofibrosarcoma Protuberans: Update on the Diagnosis and Treatment. J Clin Med, 2020, 9 (6).
[9] Ali S.S, Ahmad I, Yaseen M, Sudhy I.K. Recurrent Dermatofibrosarcoma Protuberance: A Single-center Analysis. Turkish Journal of Plastic Surgery, 2023, 31 (4): 136-42.